FDA product code JPE: Antithrombin Iii, Two Stage Clotting Time Assay

JPE is the FDA product code for antithrombin iii, two stage clotting time assay. It is a Class II device, regulated under 21 CFR 864.7060 and reviewed by the Hematology panel. FDA has cleared 1 510(k) submission under JPE. The average 510(k) review took 295 days (median 295).

Classification

FieldValue
Device nameAntithrombin Iii, Two Stage Clotting Time Assay
Device classClass II
Regulation21 CFR 864.7060
Review panelHE — Hematology
Medical specialtyHematology
Premarket route510(k)
Third-party 510(k) review eligibleYes

Compare with all 510(k) review times · Search every JPE clearance

Top JPE applicants

ApplicantClearancesLatest
Behring Diagnostics, Inc.11994-04-19

Most recent JPE clearances

510(k)ApplicantDeviceDecision dateReview days
K933125Behring Diagnostics, Inc.BERICHROM ANTITHROMBIN III (A)1994-04-19295

Recalls for JPE devices

openFDA lists no recalls for product code JPE.

HCPCS codes with matching descriptors

Text match between the FDA device name and CMS descriptors, not an official crosswalk:

Frequently asked questions

What is FDA product code JPE?

JPE is the FDA product code for antithrombin iii, two stage clotting time assay. It is a Class II device, regulated under 21 CFR 864.7060 and reviewed by the Hematology panel.

What device class is JPE?

Class II, regulation 21 CFR 864.7060. Typical premarket route: 510(k).

How long does a 510(k) take for product code JPE?

Across 1 cleared submissions the average was 295 days from receipt to decision (median 295).

Which companies have the most JPE clearances?

Behring Diagnostics, Inc. (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Hematology product codes · FDA product code lookup · 510(k) database search · 510(k) review times